Načítá se...
Combined tests of prostate specific antigen and testosterone will improve diagnosis and monitoring the progression of prostate cancer
Prostate-specific antigen (PSA) testing has been widely used to screen men for prostate cancer (PCa) and to monitor PCa progression. However, more studies have shown that around 15% of men with low or normal PSA levels have PCa. In this study, we aimed to investigate the relationship of androgen and...
Uloženo v:
| Vydáno v: | Asian J Androl |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Medknow Publications & Media Pvt Ltd
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4577595/ https://ncbi.nlm.nih.gov/pubmed/25761834 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/1008-682X.148721 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|